Comparative Safety of Originator and Biosimilar Epoetin Alfa Drugs: An Observational Prospective Multicenter Study
ConclusionThis study confirms the comparable safety profiles of originator and biosimilar epoetin alfa drugs when used in patients receiving dialysis.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
More News: Anemia | Arrhythmia | Cardiology | Dialysis | Epogen | Heart | Hemodialysis | Italy Health | Peritoneal Dialysis | Procrit | Renal Failure | Study | Transplants | Urology & Nephrology